Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: June 30, 2008
Last updated: March 15, 2012
Last verified: September 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2011
  Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: March 17, 2011